Search research articles
Contact Us
Filters
Showing results (131-140 of 241) with videos related to
Page
of 25
Sort By:
International Journal of Molecular Medicine
|
February 4, 2010
Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells
Andrew Davenport, Michael Frezza, Min Shen, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
October 12, 2012
1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity
Zhen Zhang, Caifeng Bi, Sara M Schmitt, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
December 2, 2021
Secoisolariciresinol diglucoside mitigates benzo[a]pyrene-induced liver and kidney toxicity in mice via miR-101a/MKP-1-mediated p38 and ERK pathway
Junlin Ge, Rili Hao, Xue Rong, et al.
Frontiers in Molecular Biosciences
|
October 4, 2021
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
Vinodh Kannappan, Misha Ali, Benjamin Small, et al.
Proteins
|
January 6, 2004
Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design
David M Smith, Kenyon G Daniel, Zhigang Wang, et al.
Cancer Research
|
October 3, 2007
Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects
Di Chen, Michael Frezza, Rajendra Shakya, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
June 23, 2005
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis
Di Chen, Fangyu Peng, Qiuzhi Cindy Cui, et al.
Seminars in Cancer Biology
|
December 30, 2019
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
Huanjie Yang, Xin Chen, Kai Li, et al.
Cancers
|
October 23, 2021
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
Yiming Yang, Andrew J Sanders, Q Ping Dou, et al.
Molecular Pharmacology
|
May 22, 2002
A novel beta-lactam antibiotic activates tumor cell apoptotic program by inducing DNA damage
David M Smith, Aslamuzzaman Kazi, Lisa Smith, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 241) with videos related to
Sort By:
Page
of 25
International Journal of Molecular Medicine
|
February 4, 2010
Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells
Andrew Davenport, Michael Frezza, Min Shen, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
October 12, 2012
1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity
Zhen Zhang, Caifeng Bi, Sara M Schmitt, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
December 2, 2021
Secoisolariciresinol diglucoside mitigates benzo[a]pyrene-induced liver and kidney toxicity in mice via miR-101a/MKP-1-mediated p38 and ERK pathway
Junlin Ge, Rili Hao, Xue Rong, et al.
Frontiers in Molecular Biosciences
|
October 4, 2021
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
Vinodh Kannappan, Misha Ali, Benjamin Small, et al.
Proteins
|
January 6, 2004
Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design
David M Smith, Kenyon G Daniel, Zhigang Wang, et al.
Cancer Research
|
October 3, 2007
Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects
Di Chen, Michael Frezza, Rajendra Shakya, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
June 23, 2005
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis
Di Chen, Fangyu Peng, Qiuzhi Cindy Cui, et al.
Seminars in Cancer Biology
|
December 30, 2019
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
Huanjie Yang, Xin Chen, Kai Li, et al.
Cancers
|
October 23, 2021
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
Yiming Yang, Andrew J Sanders, Q Ping Dou, et al.
Molecular Pharmacology
|
May 22, 2002
A novel beta-lactam antibiotic activates tumor cell apoptotic program by inducing DNA damage
David M Smith, Aslamuzzaman Kazi, Lisa Smith, et al.
Page
of 25